ZIF‐8‐Based Nanodelivery of Tectorigenin for Alleviating Skeletal Muscle Atrophy via Inhibition of Oxidative Stress and Inflammation
Journal of Cachexia, Sarcopenia and Muscle · 2026-12 · 17 (6)
DOI: 10.1002/jcsm.70418 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, online erschienen am 10.11.2026. Verfasst von Xia Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Neuroregeneration of Ministry of Education, Co-Innovation Cente…. Hauptthemen laut MEDLINE: Oxidative Stress, Muscular Atrophy, Inflammation, Isoflavones. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic Research Program of Jiangsu Province, Natural Science Research Projects in Universities of Jiangsu Province.
Abstract (Originalsprache)
Background
Skeletal muscle atrophy is a pathological condition characterized by a progressive loss of muscle mass and function. Its core mechanisms involve an imbalance between protein synthesis and degradation, caused by oxidative stress and inflammation. Tectorigenin (TG) shows therapeutic potential but suffers from poor solubility and bioavailability. This study developed a zeolitic imidazolate framework‐8 (ZIF‐8) nanocarrier for TG (ZIF‐8@TG) to enhance delivery efficacy against neurogenic muscle atrophy.
Methods
ZIF‐8@TG nanoparticles were synthesized and characterized for size, drug loading, release profile and cytotoxicity. Their therapeutic effects were investigated in vitro using a nutrient deprivation‐induced C2C12 myotube atrophy model and in vivo using a sciatic nerve crush injury–induced mouse model of muscle atrophy. Immunofluorescence staining and western blotting were performed to assess the effects of ZIF‐8@TG on atrophic myotubes. Behavioural tests, immunofluorescence staining and western blotting were used to evaluate its impact on muscle atrophy in vivo. The underlying mechanisms were further explored through western blotting, electron microscopy, immunofluorescence staining and H&E staining.
Results
ZIF‐8@TG nanoparticles (approx. 50 nm) exhibited pH‐responsive release and efficient cellular uptake. In vitro, nutrient deprivation reduced myotube diameter by 53% ( p < 0.01), whereas ZIF‐8@TG treatment restored it to 92% of control levels, showing significantly better efficacy than free TG. In vivo, sciatic nerve injury decreased tibialis anterior muscle mass by 35% ( p < 0.001) and mean myofiber cross‐sectional area (CSA) by 41% ( p < 0.001). ZIF‐8@TG treatment significantly increased muscle mass to 74% and CSA to 93% of control values, whereas free TG resulted in non‐significant improvements. Additionally, ZIF‐8@TG improved motor function in mice following sciatic nerve crush. Mechanistically, the alleviation of skeletal muscle atrophy by ZIF‐8@TG may be associated with regulation of excessive activation of the ubiquitin‐proteasome system and autophagy‐associated changes, along with enhanced protein synthesis–related Akt/mTOR signalling pathway during sciatic nerve crush–induced muscle atrophy, as well as an association with reduced oxidative stress and inflammation.
Conclusions
ZIF‐8@TG effectively delivers TG, alleviating muscle atrophy in vitro and in vivo. ZIF‐8@TG treatment is associated with reduced oxidative stress and inflammation, preserved protein homeostasis and improved functional recovery, offering a promising nanotechnology‐based therapy strategy for neurogenic skeletal muscle atrophy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Tissue Engineering and Neuroregeneration, Key Laboratory of Neuroregeneration of Ministry of Education, Co-Innovation Center of Neuroregeneration, Medical School of Nantong University, Nantong…
- Department of Emergency Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People's Republic of China.
- Department of Orthopedics, Changshu Hospital Affiliated to Soochow University, First People's Hospital of Changshu City, Changshu, Jiangsu, People's Republic of China.
ORCID-Profile: Lei Qi, Chuli Zhu, Yuntian Shen, Xiaosong Gu, Hualin Sun, Xinlei Yao
Förderung
- National Natural Science Foundation of China
- Basic Research Program of Jiangsu Province
- Natural Science Research Projects in Universities of Jiangsu Province
- Suzhou Science and Technology Development Program
- Nantong Science and Technology Program
Zitieren
APA
Li, X., Wei, Y., Qi, L., Dai, X., Li, Z., Zhu, C., Zhu, X., Shen, Y., Chen, B., Gu, X., Sun, H., & Yao, X. (2026). ZIF‐8‐Based Nanodelivery of Tectorigenin for Alleviating Skeletal Muscle Atrophy via Inhibition of Oxidative Stress and Inflammation. Journal of Cachexia, Sarcopenia and Muscle, 17(6). https://doi.org/10.1002/jcsm.70418
Vancouver
Li X, Wei Y, Qi L, Dai X, Li Z, Zhu C, et al. ZIF‐8‐Based Nanodelivery of Tectorigenin for Alleviating Skeletal Muscle Atrophy via Inhibition of Oxidative Stress and Inflammation. Journal of Cachexia, Sarcopenia and Muscle. 2026;17(6). doi:10.1002/jcsm.70418
BibTeX
@article{Li2026,
author = {Li, Xia and Wei, Yutong and Qi, Lei and Dai, Xiu and Li, Zhanzhan and Zhu, Chuli and Zhu, Xucheng and Shen, Yuntian and Chen, Bingqian and Gu, Xiaosong and Sun, Hualin and Yao, Xinlei},
title = {ZIF‐8‐Based Nanodelivery of Tectorigenin for Alleviating Skeletal Muscle Atrophy via Inhibition of Oxidative Stress and Inflammation},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2026},
volume = {17},
number = {6},
doi = {10.1002/jcsm.70418}
}
EUVIMED